Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30838757 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838722 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838748 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838753 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838737 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838708 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838740 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838759 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838742 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL30838717 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4597547-A1 | CHEMICAL SOLUTION, METHOD FOR PRODUCING MODIFIED SUBSTRATE, AND METHOD FOR PRODUCING LAYERED BODY | FUJIFILM Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250215024-A1 | CHEMICAL LIQUID, MANUFACTURING METHOD OF MODIFIED SUBSTRATE, AND MANUFACTURING METHOD OF LAMINATE | FUJIFILM CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| WO-2025105151-A1 | METHOD OF MANUFACTURING TREATED SUBSTRATE AND METHOD OF MANUFACTURING SEMICONDUCTOR | FUJIFILM CORPORATION (JP) | 2025-05-22 | — | — | WO | disclosed |
| CN-119768898-A | Chemical solution, method for producing modified substrate, and method for producing laminate | 富士胶片株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-111742391-B | Chemical solution for forming water-repellent protective film, method for producing same, and method for producing surface-treated body | 中央硝子株式会社 | 2025-02-18 | — | — | CN | disclosed |
| US-12098319-B2 | Liquid chemical for forming water-repellent protective film, method for preparing same, and method for manufacturing surface-treated body | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-09-24 | — | — | US | disclosed |
| WO-2024070526-A1 | CHEMICAL SOLUTION, METHOD FOR PRODUCING MODIFIED SUBSTRATE, AND METHOD FOR PRODUCING LAYERED BODY | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215024-A1 | CHEMICAL LIQUID, MANUFACTURING METHOD OF MODIFIED SUBSTRATE, AND MANUFACTURING METHOD OF LAMINATE | EPM2A, AKR7A2, ALDOA | TSHR 4812/4885THRB 4738/4885EPHX1 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.